一种适配载体用于人类睾丸精子冷冻保存
研究比较适配载体Cryoplus与常规容器冷冻精子的质量,并回顾性分析104例无精子症男性睾丸精子冷冻后的临床结局。适配载体较2ml冷冻管改善精子活力,与0.25ml麦管无差异;冻融睾丸精子行ICSI及冻胚移植的结局与新鲜睾丸精子相似。
要点
- 适配载体较2ml冷冻管改善少精精液冷冻复苏后精子活力,与0.25ml麦管无差异。
- 三种载体冷冻精子DNA碎片率无差异。
- 冻融睾丸精子行ICSI及冻胚移植的临床结局与新鲜睾丸精子相似。
核心结论
- 适配载体较2ml冷冻管改善冷冻精子活力。
- ICSI和冻胚移植结局表明适配载体冷冻睾丸精子不劣于新鲜睾丸精子。
- 适配载体用于人类睾丸精子冷冻保存简单有效,尤其适用于梗阻性无精子症。
研究设计与样本
- 采用27例少精症精液样本比较适配载体与0.25ml麦管和2ml冷冻管的冷冻精子质量。
- 采用30例睾丸精子样本研究适配载体冷冻睾丸精子的质量。
- 回顾性研究纳入104例无精子症男性,分析适配载体冷冻睾丸精子的临床结局。
- 纳入者主要为梗阻性无精子症。
主要发现
- 适配载体较2ml冷冻管改善精液样本冷冻精子活力,与0.25ml麦管无差异。
- 三种载体冷冻精子DNA碎片率无差异。
- 使用新鲜或冷冻睾丸精子的ICSI周期受精率和优质胚胎率相似。
- 使用新鲜或冷冻睾丸精子的冻胚移植周期临床妊娠率、种植率、流产率、活产率或出生体重无差异。
临床怎么用
- 作者认为适配载体用于人类睾丸精子冷冻保存简单有效,尤其适用于梗阻性无精子症。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the adapted carrier Cryoplus improve the quality of cryopreserved spermatozoa compared with the use of conventional containers, and what is the effect of the adapted carrier on clinical outcomes? DESIGN: Semen samples from 27 cases of oligozoospermia were used to investigate whether the adapted carrier improved cryopreserved sperm quality compared with the use of 0.25-ml straws and 2-ml cryogenic vials. Thirty testicular sperm samples were used to study the quality of testicular spermatozoa cryopreserved in the adapted carrier. The retrospective study included a further 104 men with azoospermia to investigate the clinical outcomes of testicular spermatozoa cryopreserved with the adapted carriers. Men with mostly obstructive azoospermia were included in this study. RESULTS: The adapted carrier improved cryopreserved spermatozoa motility of semen samples compared with 2-ml cryogenic vials but not compared with 0.25-ml straws. No differences were found in cryopreserved sperm DNA fragmentation among the three carriers. Fertilization and good-quality embryo rates were similar in ICSI cycles using fresh or cryopreserved testicular spermatozoa. Additionally, no difference was evident between frozen-thawed embryo transfer cycles using fresh or cryopreserved testicular spermatozoa in clinical pregnancy, implantation, miscarriage, live birth rates or birth weight. CONCLUSIONS: The adapted carrier improved the cryopreserved sperm motility compared with the effects of 2-ml cryogenic vials. The outcomes of intracytoplasmic sperm injection and frozen-thawed embryo transfer outcomes indicate that testicular spermatozoa cryopreserved using the adapted carrier is not inferior to fresh testicular spermatozoa. The use of the adapted carrier for cryopreserving human testicular spermatozoa especially from obstructive azoospermia is simple and effective.
引用
- Wang M, Wu Z, Hu Y, et al. An adapted carrier for the cryopreservation of human testicular spermatozoa. Reprod Biomed Online. 2018. PMID: 30366839. doi:10.1016/j.rbmo.2018.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。